5-HT7 receptors.
- Authors
- Thomas, David R; Hagan, Jim J
- Year
- 2004
- Journal
- Current drug targets. CNS and neurological disorders
- PMID
- 14965246
- DOI
- 10.2174/1568007043482633
Following the cloning of the 5-HT(7) receptor in 1993, studies to investigate 5-HT(7) receptor function in native tissues focused on identifying functional correlates that matched the pharmacological profile determined for the cloned receptor. Studies in peripheral tissues established that the 5-HT(7) receptor mediates the relaxation of smooth muscle, including the gastrointestinal tract and cardiovascular systems. Although a number of studies provided preliminary evidence for a role for the 5-HT(7) receptor in the circadian pacemaker function of the suprachiasmatic nucleus (SCN), additional studies to investigate 5-HT(7) receptor function in other brain regions have, until recently, been hindered by the absence of 5-HT(7) receptor-selective ligands. More recently, a number of 5-HT(7) receptor-selective antagonists including, SB-269970-A and SB-656104-A have been developed. Studies utilising these compounds suggest that the 5-HT(7) receptor modulates neuronal function in a number of brain areas including the hippocampus and thalamus. In turn, these findings suggest that 5-HT(7) receptor-selective ligands might prove therapeutically useful for the treatment of psychiatric disorders. In this respect there is increasing evidence to suggest that the 5-HT(7) receptor plays a role in the control of both circadian rhythms and sleep and might therefore represent a therapeutic target for the treatment of those disorders in which disturbances in circadian rhythms and sleep architecture are thought to be contributory factors. Furthermore, there is evidence to suggest that the receptor may play a role in other CNS disorders including, anxiety, cognitive disturbances and also migraine probably via both peripheral and central mechanisms. Although further studies are required to confirm the potential role of the receptor in such disorders, findings to date suggest there are exciting opportunities for the development of novel therapeutic agents acting either selectively at the 5-HT(7) receptor or whose profile of action includes an interaction with this receptor.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genome-wide association study of theta band event-related oscillations identifies serotonin receptor gene HTR7 influencing risk of alcohol dependence. | 2011 | 21184583 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Plant-derived compounds and neurodegenerative diseases: Different mechanisms of action with therapeutic potential. | Echeverry C et al. | β | 2025 | β |
| Identification of an Antagonist Targeting G Protein and Ξ²-Arrestin Signaling Pathways of 5-HT<sub>7</sub>R. | Jeong JH et al. | β | 2024 | β |
| Central nervous system effects of 5-HT<sub>7</sub> receptors: a potential target for neurodegenerative diseases. | Quintero-Villegas A et al. | β | 2022 | β |
| Participation of Hippocampal 5-HT<sub>5A</sub>, 5-HT<sub>6</sub> and 5-HT<sub>7</sub> Serotonin Receptors on the Consolidation of Social Recognition Memory. | Schmidt SD et al. | β | 2022 | β |
| Positron Emission Tomography (PET) Imaging Tracers for Serotonin Receptors. | Fu H et al. | β | 2022 | β |
| The Implication of 5-HT Receptor Family Members in Aggression, Depression and Suicide: Similarity and Difference. | Popova NK et al. | β | 2022 | β |
| International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function. | Barnes NM et al. | β | 2021 | β |
| Antidepressant-like activity and safety profile evaluation of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione derivatives as 5-HT1A receptor partial agonists. | Partyka A et al. | β | 2020 | β |
| Role of 5-HT<sub>7</sub> receptors in the immune system in health and disease. | Quintero-Villegas A et al. | β | 2019 | β |
| The investigation of possible roles of central 5-HT<sub>7</sub> receptors in antipyretic effect mechanism of paracetamol in LPS-induced hyperthermia model of mice. | Kose D et al. | β | 2019 | β |
| A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder. | Barsuglia JP et al. | β | 2018 | β |
| Improvising 5-HT<sub>7</sub>R homology model for design of high affinity ligands: model validation with docking, embrace minimization, MM-GBSA, and molecular dynamic simulations. | Jha P et al. | β | 2018 | β |
| Serotonin receptors in depression and anxiety: Insights from animal studies. | Ε»mudzka E et al. | β | 2018 | β |
| Asenapine modulates mood-related behaviors and 5-HT<sub>1A/7</sub> receptors-mediated neurotransmission. | Delcourte S et al. | β | 2017 | β |
| How serotonin receptors regulate morphogenic signalling in neurons. | Wirth A et al. | β | 2017 | β |
| In Vivo Effect of a 5-HT<sub>7</sub> Receptor Agonist on 5-HT Neurons and GABA Interneurons in the Dorsal Raphe Nuclei of Sham and PD Rats. | Wang S et al. | β | 2017 | β |
| Liver 5-HT7 receptors: A novel regulator target of fibrosis and inflammation-induced chronic liver injury in vivo and in vitro. | Polat B et al. | β | 2017 | β |
| New Trends and Current Status of Positron-Emission Tomography and Single-Photon-Emission Computerized Tomography Radioligands for Neuronal Serotonin Receptors and Serotonin Transporter. | Hazari PP et al. | β | 2017 | β |
| 5-HT7 receptor activation: procognitive and antiamnesic effects. | Meneses A et al. | β | 2015 | β |
| Serotonin 7 Receptor Variants Are Not Associated with Response to Second-Generation Antipsychotics in Japanese Schizophrenia Patients. | Takekita Y et al. | β | 2015 | β |
| The atypical antipsychotics clozapine and olanzapine promote down-regulation and display functional selectivity at human 5-HT7 receptors. | Andressen KW et al. | β | 2015 | β |
| Cellular mechanisms of the 5-HT7 receptor-mediated signaling. | Guseva D et al. | β | 2014 | β |
| Functional activation of GΞ±q via serotonin2A (5-HT2A) and muscarinic acetylcholine M1 receptors assessed by guanosine-5Χ³-O-(3-[35S]thio)triphosphate ([35S]GTPΞ³S) binding/immunoprecipitation in rat brain membranes. | Odagaki Y et al. | β | 2014 | β |
| Impact of stress on prefrontal glutamatergic, monoaminergic and cannabinoid systems. | Lapiz-Bluhm MD | β | 2014 | β |
| Interplay between serotonin 5-HT1A and 5-HT7 receptors in depressive disorders. | Naumenko VS et al. | β | 2014 | β |
| PET tracers for serotonin receptors and their applications. | Kumar JS et al. | β | 2014 | β |
| Pharmacology of serotonin and female sexual behavior. | Uphouse L | β | 2014 | β |
| Serotonin modulation of macrophage polarization: inflammation and beyond. | de Las Casas-Engel M et al. | β | 2014 | β |
| Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome. | Stasi C et al. | β | 2014 | β |
| 5-HT radioligands for human brain imaging with PET and SPECT. | Paterson LM et al. | β | 2013 | β |
| 5-Hydroxytryptamine type 7 receptor neuroprotection against NMDA-induced excitotoxicity is PDGFΞ² receptor dependent. | Vasefi MS et al. | β | 2013 | β |
| Binding of lurasidone, a novel antipsychotic, to rat 5-HT7 receptor: analysis by [3H]SB-269970 autoradiography. | Horisawa T et al. | β | 2013 | β |
| Discovery of aryl-biphenyl-2-ylmethylpiperazines as novel scaffolds for 5-HT(7) ligands and role of the aromatic substituents in binding to the target receptor. | Kim Y et al. | β | 2013 | β |
| Effects of exposure to amitraz on noradrenaline, serotonin and dopamine levels in brain regions of 30 and 60 days old male rats. | Del Pino J et al. | β | 2013 | β |
| The serotonin 5-HT7 receptors: two decades of research. | Gellynck E et al. | β | 2013 | β |
| Acute and repeated treatment with the 5-HT7 receptor antagonist SB 269970 induces functional desensitization of 5-HT7 receptors in rat hippocampus. | Tokarski K et al. | β | 2012 | β |
| Effects of the selective 5-HT(7) receptor antagonist SB-269970 in animal models of psychosis and cognition. | Waters KA et al. | β | 2012 | β |
| Involvement of 5-HTβ receptors in the pathogenesis of temporal lobe epilepsy. | Yang Z et al. | β | 2012 | β |
| Modulatory effects of two novel agonists for serotonin receptor 7 on emotion, motivation and circadian rhythm profiles in mice. | Adriani W et al. | β | 2012 | β |
| Serotonergic mechanisms as targets for existing and novel antipsychotics. | Meltzer HY | β | 2012 | β |
| Stress- and antidepressant treatment-induced modifications of 5-HTβ receptor functions in the rat brain. | Tokarski K et al. | β | 2012 | β |
| The 5-HT(7) receptor in learning and memory. | Roberts AJ et al. | β | 2012 | β |
| Estradiol modulation of cortical, striatal and raphe nucleus 5-HT1A and 5-HT2A receptors of female hemiparkinsonian monkeys after long-term ovariectomy. | SΓ‘nchez MG et al. | β | 2011 | β |
| Genome-wide association study of theta band event-related oscillations identifies serotonin receptor gene HTR7 influencing risk of alcohol dependence. | Zlojutro M et al. | β | 2011 | β |
| In vivo effect of 5-HTβ receptor agonist on pyramidal neurons in medial frontal cortex of normal and 6-hydroxydopamine-lesioned rats: an electrophysiological study. | Fan LL et al. | β | 2011 | β |
| Pharmacological blockade of serotonin 5-HTβ receptor reverses working memory deficits in rats by normalizing cortical glutamate neurotransmission. | Bonaventure P et al. | β | 2011 | β |
| Synthesis and biological evaluation of potential 5-HT(7) receptor PET radiotracers. | Andries J et al. | β | 2011 | β |
| The role of 5-hydroxytryptamine 7 receptors in the phencyclidine-induced novel object recognition deficit in rats. | Horiguchi M et al. | β | 2011 | β |
| The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment. | Meltzer HY et al. | β | 2011 | β |
| The serotonin 5-HT7Dro receptor is expressed in the brain of Drosophila, and is essential for normal courtship and mating. | Becnel J et al. | β | 2011 | β |
| Glioblastoma chemotherapy adjunct via potent serotonin receptor-7 inhibition using currently marketed high-affinity antipsychotic medicines. | Kast RE | β | 2010 | β |
| LP-211 is a brain penetrant selective agonist for the serotonin 5-HT(7) receptor. | Hedlund PB et al. | β | 2010 | β |
| New insights into homopiperazine-based 5-HT1A/5-HT7R ligands: synthesis and biological evaluation. | Badarau E et al. | β | 2010 | β |
| Phe369(7.38) at human 5-HT(7) receptors confers interspecies selectivity to antagonists and partial agonists. | Varin T et al. | β | 2010 | β |
| Asenapine: a novel psychopharmacologic agent with a unique human receptor signature. | Shahid M et al. | β | 2009 | β |
| Benzimidazolone-based serotonin 5-HT1A or 5-HT7R ligands: synthesis and biological evaluation. | Badarau E et al. | β | 2009 | β |
| Differential mediation of descending pain facilitation and inhibition by spinal 5HT-3 and 5HT-7 receptors. | Dogrul A et al. | β | 2009 | β |
| Evidence that 5-hydroxytryptamine(7) receptors play a role in the mediation of afferent transmission within the nucleus tractus solitarius in anaesthetized rats. | Oskutyte D et al. | β | 2009 | β |
| Expression and function of 5-HT7 receptors in smooth muscle preparations from equine duodenum, ileum, and pelvic flexure. | Prause AS et al. | β | 2009 | β |
| Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system. | Filip M et al. | β | 2009 | β |
| Role of 5-HT receptor mechanisms in sub-chronic PCP-induced reversal learning deficits in the rat. | McLean SL et al. | β | 2009 | β |
| Spinal 5-HT7 receptors are critical for alternating activity during locomotion: in vitro neonatal and in vivo adult studies using 5-HT7 receptor knockout mice. | Liu J et al. | β | 2009 | β |
| Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity. | Medina RA et al. | β | 2009 | β |
| The 5-HT7 receptor and disorders of the nervous system: an overview. | Hedlund PB | β | 2009 | β |
| 5-HT1A receptors in the dorsal hippocampus mediate the anxiogenic effect induced by the stimulation of 5-HT neurons in the median raphe nucleus. | Dos Santos L et al. | β | 2008 | β |
| 5-HT(7) receptors in the modulation of cognitive processes. | Cifariello A et al. | β | 2008 | β |
| Asenapine, a novel psychopharmacologic agent: preclinical evidence for clinical effects in schizophrenia. | FrΓ₯nberg O et al. | β | 2008 | β |
| Assessing the neuronal serotonergic target-based antidepressant stratagem: impact of in vivo interaction studies and knockout models. | Rajkumar R et al. | β | 2008 | β |
| Cloning, genomic organization and functionality of 5-HT(7) receptor splice variants from mouse brain. | Gellynck E et al. | β | 2008 | β |
| Contractile effects of 5-hydroxytryptamine (5-HT) in the equine jejunum circular muscle: functional and immunohistochemical identification of a 5-HT1A-like receptor. | Delesalle C et al. | β | 2008 | β |
| Current and prospective pharmacological targets in relation to antimigraine action. | Mehrotra S et al. | β | 2008 | β |
| Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: optimising brain penetration. | Peters JU et al. | β | 2008 | β |
| Effect of 5-HT(7) antagonist SB-269970 in the modulation of working and reference memory in the rat. | Gasbarri A et al. | β | 2008 | β |
| Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity. | Galici R et al. | β | 2008 | β |
| Ex vivo study of 5-HT(1A) and 5-HT(7) receptor agonists and antagonists on cAMP accumulation during memory formation and amnesia. | Perez-GarcΓa G et al. | β | 2008 | β |
| Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition. | Semenova S et al. | β | 2008 | β |
| Memory formation, amnesia, improved memory and reversed amnesia: 5-HT role. | Perez-Garcia G et al. | β | 2008 | β |
| S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptors. | Millan MJ et al. | β | 2008 | β |
| Serotomide and safflomide modulate forskolin-stimulated cAMP formation via 5-HT1 receptor. | Park JB | β | 2008 | β |
| Serotonin receptors. | Nichols DE et al. | β | 2008 | β |
| The effects of the 5-HT(6) receptor agonist EMD and the 5-HT(7) receptor agonist AS19 on memory formation. | Meneses A et al. | β | 2008 | β |
| 5-HT7, neurogenesis and antidepressants: a promising therapeutic axis for treating depression. | Nandam LS et al. | β | 2007 | β |
| Analysis of 5-HT6 and 5-HT7 receptor gene expression in rats showing differences in novelty-seeking behavior. | Ballaz SJ et al. | β | 2007 | β |
| Autoradiography reveals selective changes in serotonin binding in neocortex of patients with temporal lobe epilepsy. | Rocha L et al. | β | 2007 | β |
| Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forced swimming test in mice. | WesoΕowska A et al. | β | 2007 | β |
| Molecular signaling involved in regulating feeding and other motivated behaviors. | Gruninger TR et al. | β | 2007 | β |
| Novel interaction between the human 5-HT7 receptor isoforms and PLAC-24/eIF3k. | De Martelaere K et al. | β | 2007 | β |
| Structure of the human 5-HT7 receptor gene and characterization of its promoter region. | Laenen K et al. | β | 2007 | β |
| Synaptic transmission at functionally identified synapses in the enteric nervous system: roles for both ionotropic and metabotropic receptors. | Gwynne RM et al. | β | 2007 | β |
| The 5-HT7 receptor: role in novel object discrimination and relation to novelty-seeking behavior. | Ballaz SJ et al. | β | 2007 | β |
| An mRNA expression analysis of stimulation and blockade of 5-HT7 receptors during memory consolidation. | PΓ©rez-GarcΓa G et al. | β | 2006 | β |
| Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression. | WesoΕowska A et al. | β | 2006 | β |
| Effects of 5-HT1A and 5-HT2A receptor stimulation on temporal differentiation performance in the fixed-interval peak procedure. | Asgari K et al. | β | 2006 | β |
| Effects of 8-OH-DPAT on hippocampal NADH fluorescence in vivo in anaesthetized rats. | Rex A et al. | β | 2006 | β |
| Effects of genetic background and null mutation of 5-HT1A receptors on basal and stress-induced body temperature: modulation by serotonergic and GABAA-ergic drugs. | Van Bogaert M et al. | β | 2006 | β |
| Functional reactivity of 5-HT receptors in human umbilical cord and maternal subcutaneous fat arteries after normotensive or pre-eclamptic pregnancy. | Gupta S et al. | β | 2006 | β |
| Neuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems. | Birzniece V et al. | β | 2006 | β |
| Neuronal 5-HT metabotropic receptors: fine-tuning of their structure, signaling, and roles in synaptic modulation. | Bockaert J et al. | β | 2006 | β |
| Positive association of the serotonin 5-HT7 receptor gene with schizophrenia in a Japanese population. | Ikeda M et al. | β | 2006 | β |
| Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats. | WesoΕowska A et al. | β | 2006 | β |
| SER-7, a Caenorhabditis elegans 5-HT7-like receptor, is essential for the 5-HT stimulation of pharyngeal pumping and egg laying. | Hobson RJ et al. | β | 2006 | β |
| Systemic morphine produce antinociception mediated by spinal 5-HT7, but not 5-HT1A and 5-HT2 receptors in the spinal cord. | Dogrul A et al. | β | 2006 | β |
| Differential agonist-mediated internalization of the human 5-hydroxytryptamine 7 receptor isoforms. | Guthrie CR et al. | β | 2005 | β |
| Effects of the potential 5-HT7 receptor agonist AS 19 in an autoshaping learning task. | Perez-GarcΓa GS et al. | β | 2005 | β |
| [Neurobiology of depression: new data]. | Lanfumey L et al. | β | 2005 | β |
| Pre- and postsynaptic localization of the 5-HT7 receptor in rat dorsal spinal cord: immunocytochemical evidence. | Doly S et al. | β | 2005 | β |
| Repeated administration of citalopram and imipramine alters the responsiveness of rat hippocampal circuitry to the activation of 5-HT7 receptors. | Tokarski K et al. | β | 2005 | β |
| Serotonin 5-HT7 receptors coupled to induction of interleukin-6 in human microglial MC-3 cells. | MahΓ© C et al. | β | 2005 | β |
| Distribution of 5-HT7 receptors in the human brain: a preliminary autoradiographic study using [3H]SB-269970. | VarnΓ€s K et al. | β | 2004 | β |
| Effects of the 5-HT7 receptor antagonists SB-269970 and DR 4004 in autoshaping Pavlovian/instrumental learning task. | Meneses A | β | 2004 | β |
| Functional expression of the serotonin 5-HT7 receptor in human glioblastoma cell lines. | MahΓ© C et al. | β | 2004 | β |
| Functions of 5-HT2A receptor and its antagonists in the cardiovascular system. | Nagatomo T et al. | β | 2004 | β |
| Identification of one of the least well understood 5-HT receptors (5-HT5A) in the spinal cord. | Ramage AG | β | 2004 | β |
| The impact of spacer structure on 5-HT7 and 5-HT1A receptor affinity in the group of long-chain arylpiperazine ligands. | Bojarski AJ et al. | β | 2004 | β |